Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

NCT00005580 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

54

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: bryostatin 1
DRUG: fludarabine phosphate

Sponsor

Virginia Commonwealth University

Collaborators

[object Object]